✦ LIBER ✦

Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women

✍ Scribed by Kathleen E. Bainbridge; MaryFran Sowers; Xihong Lin; Sioban D. Harlow

Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 243 KB
Volume: 15
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s00198-003-1562-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone mineral density and risk factors fo

Bone mineral density and risk factors for osteoporosis—A population-based study of 1600 perimenopausal women

✍ H. Kröger; M. Tuppurainen; R. Honkanen; E. Alhava; S. Saarikoski 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 744 KB

Population-based epidemiological studies on osteoporosis are few. Our study evaluated the effects of menopause and certain putative behavioural risk factors on bone mineral density (BMD). Spinal and femoral neck BMD were measured with dual X-ray absorptiometry (DXA) from 1600 perimenopausal women ag

Estrogen receptor α CA dinucleotide repe

Estrogen receptor α CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women

✍ B. M. H. Lai; C. L. Cheung; K. D. K. Luk; A. W. C. Kung 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 175 KB

Risk factors for breast cancer in older

Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors

✍ Jane A. Cauley; Jingli Song; Sherie A. Dowsett; John L. Mershon; Steven R. Cummi 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 184 KB

Odanacatib in the treatment of postmenop

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

✍ John A Eisman; Henry G Bone; David J Hosking; Michael R McClung; Ian R Reid; Ren 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 211 KB 👁 2 views

## Abstract The selective cathepsin K inhibitor odanacatib (ODN) progressively increased bone mineral density (BMD) and decreased bone‐resorption markers during 2 years of treatment in postmenopausal women with low BMD. A 1‐year extension study further assessed ODN efficacy and safety and the effec

Bone mineral density in premenopausal wo

Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)

✍ I. Fogelman; G.M. Blake; R. Blamey; M. Palmer; W. Sauerbrei; M. Schumacher; D. S 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 232 KB

A specific haplotype in the 3′ end of es

A specific haplotype in the 3′ end of estrogen-receptor alpha gene is associated with low bone mineral density in premenopausal women and increased risk of postmenopausal osteoporosis

✍ B. Ongphiphadhanakul; S. Chanprasertyothin; S. Saetung; R. Rajatanavin 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 220 KB